News Tom Richards joins 21GRAMS as co-global chief creative offic... W2O advertising and marketing agency 21GRAMS has appointed Tom Richards as its co-global chief creative officer.
News W2O acquires US advertising and med ed agency 21GRAMS W2O has bought US-based advertising and medical education 21GRAMS, expanding its direct-to-consumer, direct-to-provider and business-to-business advertising and marketing operations.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
